Marc Hennequart

Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy

Mylène Tajan, Marc Hennequart, Eric C. Cheung et al. · Nature Communications · 2021 · 305 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses

Julianna Blagih, Fabio Zani, Probir Chakravarty et al. · Cell Reports · 2020 · 179 citations · Full text

Medicine, Cancer Biology, Oncology +17

Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance

Marc Hennequart, Luc Pilotte, Stefania Canè et al. · Cancer Immunology Research · 2017 · 173 citations

Medicine, Immunology, Oncology +13

Single-cell resolved imaging reveals intra-tumor heterogeneity in glycolysis, transitions between metabolic states, and their regulatory mechanisms

Hiroshi Kondo, Colin D.H. Ratcliffe, Steven Hooper et al. · Cell Reports · 2021 · 113 citations · Full text

Life Sciences, Cell Biology, Oncology +17

The dietary sweetener sucralose is a negative modulator of T cell-mediated responses

Fabio Zani, Julianna Blagih, Tim Gruber et al. · Nature · 2023 · 107 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +10